Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non‐small cell lung cancer

Lung cancer is one of the most common cancers, still characterized by high mortality rates. As lipid metabolism contributes to cancer metabolic reprogramming, several lipid metabolism genes are considered prognostic biomarkers of cancer. Statins are a class of lipid‐lowering compounds used in treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández, Lara Paula, Merino, María, Colmenarejo, Gonzalo, Moreno‐Rubio, Juan, Sánchez‐Martínez, Ruth, Quijada‐Freire, Adriana, Gómez de Cedrón, Marta, Reglero, Guillermo, Casado, Enrique, Sereno, María, Ramírez de Molina, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718959/
https://www.ncbi.nlm.nih.gov/pubmed/33030783
http://dx.doi.org/10.1002/1878-0261.12816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718959/
https://www.ncbi.nlm.nih.gov/pubmed/33030783
http://dx.doi.org/10.1002/1878-0261.12816

Ejemplares similares